24-Hour Crisis Hotline: (877)SAFEGBC or (877)723-3422 Mental Health & Substance Abuse Issues

6502 Nursery Drive, Suite 100
Victoria, TX 77904
Fax: (361)578-5500
Regular Hours: M-Fri 8am - 5pm
Every 3rd Thurs of the Month - Extended Hours Until 7 pm

Medical Disorders
Basic InformationLookupsLatest News
When Is It Time for a Knee Replacement?AHA News: Death Rates From Tears In This Major Heart Artery Are Rising, Especially Among Women, Black AdultsOmicron COVID Causing Severe Croup in Young Children'Zapping' Air Passages May Bring Relief for Severe AsthmaModerna Asks FDA to Approve Second Booster for All AdultsNew Tick-Borne Virus Is Spreading Across U.S.Memory Issues Plague Long COVID PatientsCOVID Vaccine Won't Cause Rare Neuro Events, But COVID Infection CouldTriglycerides a Stroke Danger, Even With Statin TreatmentIt Can Take Weeks for Some Patients With Severe COVID to Recover ConsciousnessOmicron Wave Had 5 Times as Many Small Kids Hospitalized Compared to DeltaBreathing Dirty Air Could Raise Your Odds for Rheumatoid ArthritisPalliative Care Crucial After Severe Stroke, But Many Patients Miss OutMammograms Can Also Highlight Heart Risks: StudyPfizer Asks FDA to Approve Second Booster for SeniorsEven a Little Light in Your Bedroom Could Harm HealthMental Issues Can Linger More Than a Year After Severe COVIDRise in U.K. COVID Cases Closely Watched by U.S. Health OfficialsLong COVID May Bring Long-Term Lung DamageNew Malaria Treatment Gets First Approval for Use in ChildrenWarming World Means More Cases of Dangerous Low-Salt ConditionAbout 1 in 6 U.S. Couples Disagrees on COVID VaccinationCOVID Meds Appear to Work Against BA.2 Omicron Variant‘Deltacron’ Variant Rare and Not a Major ConcernCould Depression Make Dry Eye Worse?When Will Americans With Diabetes Get Relief From High Insulin Prices?COVID's Global Death Toll May Be 3 Times Official NumbersDrug Could Be Non-Antibiotic Alternative to Treat UTIsFlu Vaccine No Match for Circulating Variants This SeasonLymphedema in Legs Strikes 1 in 3 Female Cancer SurvivorsScience Brings Shortcut to Spotting 50 Rare Genetic DiseasesU.S. Airplane, Train and Transit Mask Mandates Extended to April 18Man Who Received First Pig Heart Transplant Has DiedPfizer Begins Trial of COVID Drug Paxlovid in Kids 6 to 17Could a Stool Test Help Spot Pancreatic Cancer?Upcoming Surgery Worry You? Poll Says You're Not AloneHalf of Americans Live With Legacy of Childhood Lead PoisoningIn Reversal, WHO Now Supports COVID BoostersLooking to Neanderthals to Explain Today's Lower Back PainWhat's More Accurate, Blood Pressure Readings at Home or Doctor's Office?Begin Now to Protect Your Heart as Clocks 'Spring Forward'Brain Changes May Fuel 'Long COVID' Anxiety, ConfusionAHA News: Break Up Binge-Watching by Taking a StandHow COVID-19 Can Change the BrainHeart Defects Could Raise Odds for Severe COVID-196 Healthy Steps to Preventing Colon CancerAHA News: These Three Risk Factors May Have the Biggest Impact on Dementia CasesU.S. Surgeon General Investigates COVID-19 MisinformationLong or Irregular Periods May Put a Woman's Liver at RiskCould Your Blood Type Make COVID Worse?
Questions and AnswersLinks
Related Topics


New Clues to Why Some Develop 'Brain Fog' After COVID

HealthDay News
by Robert Preidt
Updated: Jan 20th 2022

new article illustration

THURSDAY, Jan. 20, 2022 (HealthDay News) -- Brain fog. It has become an inexplicable side effect of COVID-19 infection, but researchers now report they have discovered a possible reason why it happens.

In a small study, investigators found abnormalities in the cerebrospinal fluid of some COVID-19 patients who developed thinking problems.

The symptoms "manifest as problems remembering recent events, coming up with names or words, staying focused, and issues with holding onto and manipulating information, as well as slowed processing speed,” explained study senior author Dr. Joanna Hellmuth, from the Memory and Aging Center at the University of California, San Francisco.

Brain fog is a common aftereffect of COVID infection, striking about 67% of 156 patients at a post-COVID clinic in New York, a recent study found.

In this latest study, the researchers analyzed the cerebrospinal fluid of 13 people who had thinking and memory problems after COVID-19 and of four recovered COVID-19 patients with no cognitive symptoms.

The average age of those with cognitive symptoms was 48, compared with 39 for those with no cognitive symptoms. The cerebrospinal fluid samples were collected an average of 10 months after the patients' first COVID-19 symptoms. None of the patients were hospitalized for COVID-19.

Cerebrospinal fluid anomalies were found in 10 of the 13 patients with cognitive symptoms, but not in any of the four with no cognitive symptoms, according to the study published Jan. 19 in the journal Annals of Clinical and Translational Neurology.

The cerebrospinal fluid of patients with cognitive symptoms had elevated levels of protein, suggesting inflammation, as well as unexpected antibodies found in an activated immune system.

Some of those antibodies were found in both cerebrospinal fluid and blood, indicating a systemic inflammatory response, or were found only in cerebrospinal fluid, suggesting brain inflammation.

While the targets of these antibodies are unknown, they could be “turncoat” antibodies that attack the body itself, according to the researchers.

"It's possible that the immune system, stimulated by the virus, may be functioning in an unintended pathological way," said Hellmuth, who is principal investigator of the UCSF Coronavirus Neurocognitive Study and is also affiliated with the UCSF Weill Institute for Neurosciences.

"This would be the case even though the individuals did not have the virus in their bodies," she said in a university news release.

The study also found that participants with thinking problems had an average of 2.5 risk factors for impaired thinking, compared with an average of less than one risk factor for participants without the symptoms.

Those risk factors included: diabetes and high blood pressure, which can increase the risk of stroke, mild cognitive impairment and vascular dementia; a history of attention deficit hyperactivity disorder (ADHD), which may make the brain more vulnerable to executive functioning issues; anxiety; depression; a history of heavy alcohol or repeated stimulant use; and learning disabilities.

More information

For more on COVID-19 brain fog, go to Harvard Medical School.

SOURCE: University of California, San Francisco, news release, Jan. 18, 2022